Diagnosis Code D07.5
Information for Medical Professionals
The following edits are applicable to this code:
Diagnoses for males only Diagnoses for males only
Diagnoses for males only.
Diagnostic Related Groups
The diagnosis code D07.5 is grouped in the following Diagnostic Related Group(s) (MS-DRG v33.0)
- OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC 715
- OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC 716
- OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC 717
- OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC EXCEPT MALIGNANCY WITHOUT CC/MCC 718
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 233.4 - Ca in situ prostate
- Carcinoma in situ of prostate
- Carcinoma in situ of prostatic ducts
- High grade prostatic intraepithelial neoplasia
- Prostatic intraepithelial neoplasia
- Prostatic intraepithelial neoplasia and adjacent atypia
Index of Diseases and Injuries
References found for the code D07.5 in the Index of Diseases and Injuries:
- Inclusion Terms: Inclusion terms
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Prostatic intraepithelial neoplasia III (PIN III)
- Severe dysplasia of prostate
- Type 1 Excludes Notes: Type 1 Excludes Notes
A type 1 Excludes note is a pure excludes note. It means “NOT CODED HERE!” An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- dysplasia (mild) (moderate) of prostate (N42.3-)
- prostatic intraepithelial neoplasia II [PIN II] (N42.3-)
Information for Patients
The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40. Risk factors for developing prostate cancer include being over 65 years of age, family history, and being African-American.
Symptoms of prostate cancer may include
- Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling
- Low back pain
- Pain with ejaculation
To diagnose prostate cancer, you doctor may do a digital rectal exam to feel the prostate for lumps or anything unusual. You may also get a blood test for prostate-specific antigen (PSA). These tests are also used in prostate cancer screening, which looks for cancer before you have symptoms. If your results are abnormal, you may need more tests, such as an ultrasound, MRI, or biopsy.
Treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Men with prostate cancer have many treatment options. The treatment that's best for one man may not be best for another. The options include watchful waiting, surgery, radiation therapy, hormone therapy, and chemotherapy. You may have a combination of treatments.
NIH: National Cancer Institute
- Cryotherapy for prostate cancer
- Digital rectal exam
- Gleason grading system
- Hormone therapy for prostate cancer
- Pelvic (between the hips) radiation - discharge
- Prostate brachytherapy
- Prostate cancer
- Prostate cancer - treatment
- Prostate cancer staging
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about Brachytherapy (A Type of Internal Radiation Therapy) - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)